We are committed to finding a cure for WM.

Did you know?

 

Welcome to the Waldenstrom’s Macroglobulinemia Foundation of Canada (WMFC)

If you have been diagnosed with Waldenstrom’s Macroglobulinemia (WM) or care for someone who has, welcome to the WMFC family of WM patients, caregivers, friends and relatives. We are a community providing support, research and information on WM.

Sign up for our newsletter below to receive updated information.

 

Information for the newly diagnosed

Ibrutinib Highly Active, Safe for Waldenström Macroglobulinemia

Source: https://www.oncnet.com/news/ibrutinib-highly-active-safe-waldenstrom-macroglobulinemia Patients with symptomatic Waldenström macroglobulinemia (WM) benefit from first-line treatment with ibrutinib, which Steven P. Treon, MD, PhD, Bing Center for Waldenström Macroglobulinemia, Dana Farber Cancer Institute, Boston, Read More

October is Membership Month!

  “When we work together we have the power to take problems head on and make a difference in our life and in the lives of others around us.”    Read More

Pivotal Trial Underway for Zanubrutinib in Waldenström Macroglobulinemia

Source: https://www.cancertherapyadvisor.com/hematologic-cancers/waldenstrom-macroglobulinemia-zanubrutinib-new-trial-treatment/article/801383/ A head-to-head, open-label, multicenter, phase 3 clinical trial comparing the efficacy and safety of zanubrutinib (BGB-3111) with ibrutinib in patients with Waldenström macroglobulinemia (WM) is underway (ClinicalTrials.org Identifier: NCT03053440).1 The study also Read More

Subscribe to our newsletter